Сo-infecția TB/HIV: factori de risc și provocări pentru sistemul de sănătate

Autori

  • Oxana PLAMADEALA IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”
  • Valentina VILC IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”
  • Serghei PISARENCO IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”

DOI:

https://doi.org/10.52692/1857-0011.2024.2-79.29

Cuvinte cheie:

co - infecție, tuberculoză, HIV, screening - ul sistematic, factori de risc

Rezumat

TB/HIV coinfection remains a serious issue for healthcare systems, especially in resource-limited countries. This study highlights the main risk factors, including weakened immunity in HIV-infected patients, as well as socioeconomic and behavioral factors, such as poverty, smoking, alcohol abuse, and drug use. The importance of a comprehensive approach to the prevention and treatment of TB/HIV coinfection is emphasized, which includes preventive treatment of TB infection, regular monitoring of immune status, improvement of living conditions, and implementation of programs to enhance adherence to TB treatment and reduce barriers to healthcare access.

Biografii autori

Oxana PLAMADEALA, IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”

 ftiziopneumolog, doctorandă

Valentina VILC, IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”

m. m. s. p.,

Serghei PISARENCO, IMSP Institutul de Ftiziopneumologie “Chiril Draganiuc”

dr. hab. în șt. med., conf. univer.

Referințe

Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. The Cochrane database of systematic reviews. 2019;10:CD011420- CD.

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update.

Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T et al. Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis. Lancet HIV. 2022;9:e233-e41.

HG Nr. 107 din 23-02-2022 privind aprobarea Programului național de răspuns la tuberculoză pentru anii 2022-2025/Publicat: 04-03-2022 în Monitorul Oficial Nr. 61-67 art. 154.

Ordinul MS nr. 432 din 11.05.2022 „Cu privire la implementarea Programului National de răspuns la tuberculoza pentru anii 2022-2025”.

Ordinul MS Nr.121 din 31/01/2024: Cu privire la aprobarea Protocolului clinic național “Tuberculoza la adult”, editia VI si Protocolul cilnic national “Tuberculoza la adult”, editia VI.

Ordinul MS Nr.481 din 31/05/2023: Cu privire la aprobarea Ghidului “Organizarea si desfasurarea screening-ului sistematic si a tratamentului preventiv al tuberculozei” si ghidul “Organizarea si desfasurarea screening-ului sistematic si a tratamentului preventiv al tuberculozei”

Sweeney S, Laurence YV, Cunnama L, Gomez GB, Garcia-Baena I, Bhide P et al. Cost of TB services: approach and summary findings of a multi-country study (Value TB). Int J Tuberc Lung Dis. 2022;26:1006-15.

WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340255).

WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – tests for tuberculosis infection. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/362936).

WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/353829).

WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/365308).

WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities. Geneva: World Health Organization; 2023.

World Health Organization (WHO). Global Tuberculosis Report 2024. 29 October 2024 https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024.

WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012 (https://apps.who.int/iris/handle/10665/44789).

Eliminating HIV, viral hepatitis, sexually transmitted infections and tuberculosis as public health problems by 2030 in lusophone countries, 25 October 2024 https:// www.who.int/publications/i/item/9789240100398.

Descărcări

Publicat

2025-04-18

Număr

Secțiune

Articol de cercetare

##category.category##